Show simple item record

 
dc.contributorHospital General de Granollers
dc.contributor.authorGimenez-Perez, Gabriel
dc.contributor.authorFranch-Nadal, Josep
dc.contributor.authorOrtega, Emilio
dc.contributor.authorMata-Cases, Manel
dc.contributor.authorGoday Arno, Albert Albert
dc.contributor.authorReal, Jordi
dc.contributor.authorRodriguez, Angel
dc.contributor.authorVlacho, Bogdan
dc.contributor.authorMauricio-Puente, Dídac
dc.date.accessioned2021-10-22T11:33:29Z
dc.date.available2021-10-22T11:33:29Z
dc.date.issued2021-04-06
dc.identifier.citationGimenez-Perez G, Franch-Nadal J, Ortega E, Mata-Cases M, Goday A, Real J, et al. Clinical Characteristics and Degree of Glycemic and Cardiovascular Risk Factor Control in Patients with Type 1 Diabetes in Catalonia (Spain). J Clin Med. 2021 Apr 6;10(7):1536.
dc.identifier.urihttp://hdl.handle.net/11351/6450
dc.descriptionType-1 diabetes; Cardiovascular risk factors; Glucose control; Complications
dc.description.abstractBackground: This study aims to evaluate the clinical characteristics, complications, degree of glycemic control, and cardiovascular risk factor control in patients with type 1 diabetes in Catalonia (Northwest of Spain). Methods: Cross-sectional study using a database including clinical, laboratory, and treatment data. Patients with an ICD10 diagnosis of type 1 diabetes were included, excluding those treated with glucose-lowering agents other than insulin, or treated only with basal insulin two years after diagnosis. Results: 15,008 patients were analysed. Median IQR age was 42 (31–53) years, diabetes duration 11.8 (6.8–16.0) years, 56.5% men. Median (IQR) HbA1c was 7.9% (7.1–8.8). Microvascular complications were present in 24.4% of patients, 43.6% in those with a diabetes duration >19 years. In presence of known cardiovascular disease 69.3% of patients showed an LDL-C concentration >70 mg/dL, 37% had a systolic blood pressure >135 mmHg and 22.4% were smokers. Conclusions: This study provides a reliable snapshot about the clinical situation of a large population of patients with T1D in Catalonia, which is similar to that of other western areas. The lack of adequate control of cardiovascular risk factors in a significant proportion of patients with cardiovascular disease deserves a more detailed analysis and urges the need for improvement strategies.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesJournal of Clinical Medicine;10(7)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectDiabetis - Catalunya
dc.subjectGlucèmia - Control
dc.subjectSistema cardiovascular - Factors de risc
dc.subject.meshDiabetes Mellitus, Type 1
dc.subject.meshBlood Glucose
dc.subject.meshCardiovascular Diseases
dc.subject.meshCatalonia
dc.titleClinical Characteristics and Degree of Glycemic and Cardiovascular Risk Factor Control in Patients with Type 1 Diabetes in Catalonia (Spain)
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/jcm10071536
dc.subject.decsdiabetes mellitus tipo I
dc.subject.decsglucosa sanguínea
dc.subject.decsenfermedades cardiovasculares
dc.subject.decsCataluña
dc.relation.publishversionhttps://doi.org/10.3390/jcm10071536
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.authoraffiliation[Gimenez-Perez, G] Hospital General de Granollers, Granollers, Spain. [Franch-Nadal, J] DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. Primary Health Care Centre Raval Sud, Gerència d’Atenció Primària Barcelona Ciutat, Institut Català de la Salut, Barcelona, Spain. [Ortega, E] Department of Endocrinology & Nutrition, Institut d’Investigacions Biomèdiques August Pi Suñer, CIBEROBN, Hospital Clínic Barcelona, Barcelona, Spain. [Mata-Cases, M] DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. Primary Health Care Centre La Mina, Gerència d’Atenció Primària Barcelona Ciutat, Institut Català de la Salut, Sant Adrià del Besós, Spain. [Goday, A] Department of Endocrinology & Nutrition, Hospital del Mar, Barcelona, Spain. Department of Medicine, Universitat Autònoma de Barcelona, CIBEROBN, Barcelona, Spain. [Real, J] DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. [Rodriguez, A] Department of Clinical Research, Lilly, S.A., Madrid, Spain. [Vlacho, B] DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. [Mauricio, D] DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. Department of Endocrinology & Nutrition, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Faculty of Medicine, University of Vic-Central University of Catalonia, Vic, Spain
dc.identifier.pmid33917523
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record